Current Prospects of Phytochemical-Based Treatment for Ovarian Cancer: A Brief Review

[1]  Heli Li,et al.  BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression , 2022, Molecular and Cellular Biochemistry.

[2]  H. Fang,et al.  Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis , 2021, Journal of Ovarian Research.

[3]  S. Deng,et al.  Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment , 2021, Antioxidants.

[4]  Qiqi Xu,et al.  Apigenin Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression , 2021, Frontiers in Oncology.

[5]  K. Kim,et al.  The inhibitory effect of curcumin via fascin suppression through JAK/STAT3 pathway on metastasis and recurrence of ovary cancer cells , 2020, BMC Women's Health.

[6]  Juan Wang,et al.  PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer , 2020, Oncology reports.

[7]  G. Sethi,et al.  Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review , 2020, Molecules.

[8]  P. Ranjekar,et al.  Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice , 2020, Frontiers in Pharmacology.

[9]  S. Kakar,et al.  Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling , 2019, Journal of ovarian research.

[10]  D. Hoskin,et al.  10-Gingerol Inhibits Ovarian Cancer Cell Growth by Inducing G2 Arrest , 2019, Advanced pharmaceutical bulletin.

[11]  Ying He,et al.  6-shogaol a Active Component from Ginger Inhibits Cell Proliferation and Induces Apoptosis through Inhibition of STAT-3 Translocation in Ovarian Cancer Cell Lines (A2780) , 2019, Biotechnology and Bioprocess Engineering.

[12]  Z. Asemi,et al.  Quercetin: a natural compound for ovarian cancer treatment , 2019, Journal of Ovarian Research.

[13]  H. Salehiniya,et al.  Ovarian cancer in the world: epidemiology and risk factors , 2019, International journal of women's health.

[14]  S. Lockwood,et al.  Ovarian Cancer: An Integrated Review. , 2019, Seminars in oncology nursing.

[15]  Xuan-jun Wang,et al.  EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice , 2018, Front. Pharmacol..

[16]  B. Karlan,et al.  Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. , 2018, Gynecologic oncology.

[17]  E. Kolb,et al.  Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy. , 2018, Cancer research.

[18]  Jinhua Dong,et al.  The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax , 2017, International Journal of Gynecologic Cancer.

[19]  N. Hacker,et al.  Surgery for advanced epithelial ovarian cancer. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[20]  Thomas A. Sellers,et al.  Epidemiology of ovarian cancer: a review , 2017, Cancer biology & medicine.

[21]  A. Toss,et al.  Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes , 2015, BioMed research international.

[22]  Fei Liu,et al.  Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3‑derived sphere-forming cells. , 2015, Molecular medicine reports.

[23]  Ling Xu,et al.  Role of JNK Activation and Mitochondrial Bax Translocation in Allicin-Induced Apoptosis in Human Ovarian Cancer SKOV3 Cells , 2014, Evidence-based complementary and alternative medicine : eCAM.

[24]  Huan Wang,et al.  Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells , 2014, Oxidative medicine and cellular longevity.

[25]  M. Pike,et al.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. , 2013, Endocrine-related cancer.

[26]  C. Landen,et al.  Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. , 2013, Experimental cell research.

[27]  Lan Shen,et al.  Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression , 2012, Archives of Gynecology and Obstetrics.

[28]  S. Pignata,et al.  Chemotherapy in epithelial ovarian cancer. , 2011, Cancer letters.

[29]  S. Shukla,et al.  Apigenin: A Promising Molecule for Cancer Prevention , 2010, Pharmaceutical Research.

[30]  M. Roett,et al.  Ovarian cancer: an overview. , 2009, American family physician.

[31]  R. Kuchta,et al.  Introduction to cancer chemotherapeutics. , 2009, Chemical reviews.

[32]  Liz Y. Han,et al.  Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway , 2007, Clinical Cancer Research.

[33]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[34]  P. Nygren.  What is cancer chemotherapy? , 2001, Acta oncologica.

[35]  Mi Ju Kim.  The inhibitory effect of curcumin via fascin suppression through JAK/STAT3 pathway on metastasis and recurrence of ovary cancer cells , 2020 .

[36]  S. Siddiqui,et al.  Phytochemicals in the treatment of ovarian cancer. , 2017, Frontiers in bioscience.

[37]  S. Tworoger,et al.  Obesity and Ovarian Cancer. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[38]  B. Karlan,et al.  OVARIAN CANCER , 2016, Nature Reviews Disease Primers.

[39]  J. Higginson.  International Agency for Research on Cancer. , 1968, WHO chronicle.